ImmunoCellular Therapeutics Presentation at Cancer Immunotherapy Conference

This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.

Featuring :

• Manish Singh, PhD, President & Chief Executive Officer, ImmunoCellular Therapeutics, Ltd., (OTC:IMUC.OB)

SEC Disclaimer Statement :

This presentation contains certain “forward-looking statements” (statements as to matters other than historical facts) as defined in the Private Securities Litigation Reform Act and in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events, projections or results described in the forward-looking statements. These risks and uncertainties are described in IMUC’s most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K.

Related Videos:

1. Dendreon Presentation at Cancer Immunotherapy Conference
2. Celldex Presentation at Cancer Immunotherapy Conference
3. Biovest International Presentation at Cancer Immunotherapy Conference
4. Provectus Presentation at Cancer Immunotherapy Conference
5. Northwest Biotherapeutics Presentation at Cancer Immunotherapy Conference
6. Argos Therapeutics Presentation at Cancer Immunotherapy Conference
7. BioSante Presentation at Cancer Immunotherapy Conference
8. Vaccinogen Presentation at Cancer Immunotherapy Conference
9. Inovio Presentation at Cancer Immunotherapy Conference
10. Bavarian Presentation at Cancer Immunotherapy Conference